Literature DB >> 18362401

Emergence of tetracycline-resistant Vibrio cholerae O1 serotype Inaba, in Kolkata, India.

Amit Roychowdhury1, Arpita Pan, Dharitri Dutta, Asish Kumar Mukhopadhyay, T Ramamurthy, Ranjan Kumar Nandy, Sujit Kumar Bhattacharya, Mihir Kumar Bhattacharya.   

Abstract

Out of 2,235 diarrheal stool samples collected from patients admitted to the Infectious Diseases Hospital, Kolkata, 343 cases were positive for Vibrio cholerae (341, V. cholerae O1 and 2, O139). During the year 2004, infections caused by V. cholerae serotype Ogawa and Inaba were 93 and 7%, respectively, while in 2005, the Inaba isolation rate rose to 88% as compared to 12% for Ogawa. Susceptibility to antimicrobial agents revealed that the O1 strains were resistant to multiple antibiotics (ampicillin, co-trimoxazole, furazolidone, nalidixic acid and streptomycin) with reduced susceptibility to ciprofloxacin. Increased isolation of tetracycline-resistant strains (27.3% for Ogawa and 15% for Inaba) was noted in 2005. It appears that the population might be at risk of infection by the Inaba serotype and that tetracycline may not be useful for the treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18362401

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  15 in total

1.  Cholera in India: an analysis of reports, 1997-2006.

Authors:  S Kanungo; B K Sah; A L Lopez; J S Sung; A M Paisley; D Sur; J D Clemens; G Balakrish Nair
Journal:  Bull World Health Organ       Date:  2010-03       Impact factor: 9.408

2.  A cholera outbreak of the Vibrio cholerae O1 El Tor variant carrying classical CtxB in northeastern Thailand in 2007.

Authors:  Kazuhisa Okada; Siriporn Chantaroj; Amonrattana Roobthaisong; Shigeyuki Hamada; Pathom Sawanpanyalert
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

3.  A high-throughput screening assay for inhibitors of bacterial motility identifies a novel inhibitor of the Na+-driven flagellar motor and virulence gene expression in Vibrio cholerae.

Authors:  Lynn Rasmussen; E Lucile White; Ashish Pathak; Julio C Ayala; Hongxia Wang; Jian-He Wu; Jorge A Benitez; Anisia J Silva
Journal:  Antimicrob Agents Chemother       Date:  2011-06-27       Impact factor: 5.191

4.  Classification of hybrid and altered Vibrio cholerae strains by CTX prophage and RS1 element structure.

Authors:  Je Hee Lee; Seon Young Choi; Yoon-Seong Jeon; Hye Ri Lee; Eun Jin Kim; Binh Minh Nguyen; Nguyen Tran Hien; M Ansaruzzaman; M Sirajul Islam; Nurul A Bhuiyan; S K Niyogi; B L Sarkar; G Balakrish Nair; Dae Shick Kim; Anna Lena Lopez; Cecil Czerkinsky; John D Clemens; Jongsik Chun; Dong Wook Kim
Journal:  J Microbiol       Date:  2010-02-04       Impact factor: 3.422

5.  Emerging trends in the etiology of enteric pathogens as evidenced from an active surveillance of hospitalized diarrhoeal patients in Kolkata, India.

Authors:  Gopinath Balakrish Nair; Thandavarayan Ramamurthy; Mihir Kumar Bhattacharya; Triveni Krishnan; Sandipan Ganguly; Dhira Rani Saha; Krishnan Rajendran; Byomkesh Manna; Mrinmoy Ghosh; Keinosuke Okamoto; Yoshifumi Takeda
Journal:  Gut Pathog       Date:  2010-06-05       Impact factor: 4.181

6.  A quinazoline-2,4-diamino analog suppresses Vibrio cholerae flagellar motility by interacting with motor protein PomB and induces envelope stress.

Authors:  Hongxia Wang; Li Zhang; Anisia J Silva; Jorge A Benitez
Journal:  Antimicrob Agents Chemother       Date:  2013-06-03       Impact factor: 5.191

7.  Resistance to ceftriaxone in Vibrio cholerae.

Authors:  Jharna Mandal; V Preethi; R Vasanthraja; S Srinivasan; Subhash Chandra Parija
Journal:  Indian J Med Res       Date:  2012-10       Impact factor: 2.375

8.  Tetracycline-resistant Vibrio cholerae O1, Kolkata, India.

Authors:  Koel Bhattacharya; Suman Kanungo; Dipika Sur; Banwari Lal Sarkar; Byomkesh Manna; Anna Lena Lopez; Manjira Bhattacharya; Suman Nandy; Swapan Kumar Niyogi
Journal:  Emerg Infect Dis       Date:  2011-03       Impact factor: 6.883

9.  Increasing antimicrobial resistance of Vibrio cholerae OI biotype E1 tor strains isolated in a tertiary-care centre in India.

Authors:  Jharna Mandal; K P Dinoop; Subhash Chandra Parija
Journal:  J Health Popul Nutr       Date:  2012-03       Impact factor: 2.000

10.  Targeting the replication initiator of the second Vibrio chromosome: towards generation of vibrionaceae-specific antimicrobial agents.

Authors:  Yoshiharu Yamaichi; Stéphane Duigou; Elizabeth A Shakhnovich; Matthew K Waldor
Journal:  PLoS Pathog       Date:  2009-11-20       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.